Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,699,748 papers from all fields of science
Search
Sign In
Create Free Account
cinaciguat
Known as:
4-(((4-Carboxybutyl)(2-(2-((4-(2-Phenylethyl)Phenyl)Methoxy)Phenyl)Ethyl)Amino)Methyl)Benzoic Acid
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
BAY 58-2667
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
M. Ruppert
,
S. Korkmaz‐Icöz
,
+11 authors
G. Szabó
Frontiers in Physiology
2019
Corpus ID: 57573910
Background: Pressure unloading induces the regression of left ventricular myocardial hypertrophy (LVH). Recent findings indicate…
Expand
2019
2019
sGC Stimulators and Activators
H. Tolppanen
,
P. Ponikowski
International Cardiovascular Forum Journal
2019
Corpus ID: 208453487
Nitric oxide (NO)-soluble guanylate cyclase(sGC)-cGMP signalling is impaired in HF syndromes, which could predispose to vascular…
Expand
2016
2016
[Expression of PAI-2 mRNA in peripheral blood leucocytes and regulation by sGC activator in pulmonary hypertension].
L. Zou
,
S. Zhang
,
X. M. Xu
,
F. Xiao
,
Z. Zhai
Zhonghua yi xue za zhi
2016
Corpus ID: 19147763
OBJECTIVE To investigate the mRNA expression level of plasminogen activator inhibitor-2 (PAI-2) in peripheral blood leucocytes…
Expand
Review
2016
Review
2016
Treatment of hypoxemic respiratory failure in neonates: past, present and future
R. Steinhorn
Journal of Perinatology
2016
Corpus ID: 26293187
Despite advances in the field of neonatology, hypoxemic respiratory failure (HRF) and persistent pulmonary hypertension of the…
Expand
2015
2015
NO/GMP as mediators of estrogen effects in bone
Hema Kalyanaraman
,
Jisha Joshua
,
Shunhui Zhuang
,
E. Corey
,
R. Sah
,
R. Pilz
BMC Pharmacology and Toxicology
2015
Corpus ID: 256364024
2011
2011
Treatment of acute decompensated heart failure with the soluble guanylate cyclase activator cinaciguat: The COMPOSE program – three randomized, controlled, phase IIb studies
M. Gheorghiade
,
E. Erdmann
,
+5 authors
C. Nowack
2011
Corpus ID: 73112973
2010
2010
CINACIGUAT, A SOLUBLE GUANYLATE CYCLASE ACTIVATOR, UNLOADS THE HEART IN ACUTE DECOMPENSATED HEART FAILURE
E. Erdmann
,
M. Semigran
,
M. Nieminen
,
R. Agrawal
,
V. Mitrović
,
A. Mebazaa
2010
Corpus ID: 72703295
2010
2010
Cinaciguat (A Soluble Guanylate Cyclase Activator)
Y. Akashi
2010
Corpus ID: 72178304
Highly Cited
2009
Highly Cited
2009
Cinaciguat ( BAY 58 – 2667 ) Improves Cardiopulmonary Hemodynamics in Patients With Acute Decompensated Heart Failure
H. Lapp
,
V. Mitrović
,
+7 authors
R. Frey
2009
Corpus ID: 207603517
Background—Cinaciguat (BAY 58–2667) is the first of a new class of soluble guanylate cyclase activators in clinical development…
Expand
2009
2009
Pharmacological activation of soluble guanylate cyclase activator protects the heart against isoproterenol-induced myocardial ischemia in rats
S. Korkmaz
,
T. Radovits
,
+8 authors
G. Szabó
BMC Pharmacology
2009
Corpus ID: 43465857
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE